1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. South Korea >
  5. Helixmith Acquires Helixir Co.

M&A Deal Summary

Helixmith Acquires Helixir Co.

On November 10, 2009, Helixmith acquired life science company Helixir Co.

Acquisition Highlights
  • This is Helixmith’s 1st transaction in the Life Science sector.
  • This is Helixmith’s 1st transaction in South Korea.

M&A Deal Summary
Date 2009-11-10
Target Helixir Co.
Sector Life Science
Buyer(s) Helixmith
Deal Type Add-on Acquisition

Target

Helixir Co.

Seoul, South Korea
Helixir Co., Ltd. is a developer of nutraceuticals and pharmaceuticals from herbal medicines in the United States, Japan, the European Union, and Korea.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Helixmith

Seoul, South Korea
Category Company
Founded 1996
Sector Life Science
Employees106
Revenue 5.0B KRW (2024)
DESCRIPTION

Helixmith is a biotechnology company develops bio-pharmaceuticals for human diseases in South Korea. Helixmith was founded in 1996 and is based in Seoul, South Korea.

DEAL STATS #
Overall 1 of 2
Sector: Life Science M&A 1 of 2
Type: Add-on Acquisition M&A Deals 1 of 1
Country: South Korea M&A 1 of 1
Year: 2009 M&A 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-08-22 Vical - GMP Facility

San Diego, California, United States

Vical Inc. - GMP Facility is a production site was used for clinical studies that included phase 3 trials in the U.S. of DNA-based investigational drugs.

Buy -
Mergr

Solution for

Product

Company

Legal